Cargando…

Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology

While the impact of combustible cigarette smoking on cardiovascular disease (CVD) is well-established, the longitudinal association of non-traditional tobacco products with subclinical and clinical CVD has not been fully explored due to: 1) limited data availability; and 2) the lack of well-phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasdighi, Erfan, Jha, Kunal K., Dardari, Zeina A., Osuji, Ngozi, Rajan, Tanuja, Boakye, Ellen, Hall, Michael E., Rodriguez, Carlos J., Stokes, Andrew C., El Shahawy, Omar, Benjamin, Emelia J., Bhatnagar, Aruni, DeFilippis, Andrew P., Blaha, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326890/
https://www.ncbi.nlm.nih.gov/pubmed/37427074
http://dx.doi.org/10.18332/tid/166517
_version_ 1785069517123092480
author Tasdighi, Erfan
Jha, Kunal K.
Dardari, Zeina A.
Osuji, Ngozi
Rajan, Tanuja
Boakye, Ellen
Hall, Michael E.
Rodriguez, Carlos J.
Stokes, Andrew C.
El Shahawy, Omar
Benjamin, Emelia J.
Bhatnagar, Aruni
DeFilippis, Andrew P.
Blaha, Michael J.
author_facet Tasdighi, Erfan
Jha, Kunal K.
Dardari, Zeina A.
Osuji, Ngozi
Rajan, Tanuja
Boakye, Ellen
Hall, Michael E.
Rodriguez, Carlos J.
Stokes, Andrew C.
El Shahawy, Omar
Benjamin, Emelia J.
Bhatnagar, Aruni
DeFilippis, Andrew P.
Blaha, Michael J.
author_sort Tasdighi, Erfan
collection PubMed
description While the impact of combustible cigarette smoking on cardiovascular disease (CVD) is well-established, the longitudinal association of non-traditional tobacco products with subclinical and clinical CVD has not been fully explored due to: 1) limited data availability; and 2) the lack of well-phenotyped prospective cohorts. Therefore, there is the need for sufficiently powered well-phenotyped datasets to fully elucidate the CVD risks associated with non-cigarette tobacco products. The Cross-Cohort Collaboration (CCC)-Tobacco is a harmonized dataset of 23 prospective cohort studies predominantly in the US. A priori defined variables collected from each cohort included baseline characteristics, details of traditional and non-traditional tobacco product use, inflammatory markers, and outcomes including subclinical and clinical CVD. The definitions of the variables in each cohort were systematically evaluated by a team of two physician-scientists and a biostatistician. Herein, we describe the method of data acquisition and harmonization and the baseline sociodemographic and risk profile of participants in the combined CCC-Tobacco dataset. The total number of participants in the pooled cohort is 322782 (mean age: 59.7 ± 11.8 years) of which 76% are women. White individuals make up the majority (73.1%), although there is good representation of other race and ethnicity groups including African American (15.6%) and Hispanic/Latino individuals (6.4%). The prevalence of participants who never smoked, formerly smoked, and currently smoke combustible cigarettes is 50%, 36%, and 14%, respectively. The prevalence of current and former cigar, pipe, and smokeless tobacco is 7.3%, 6.4%, and 8.6%, respectively. E-cigarette use was measured only in follow-up visits of select studies, totaling 1704 former and current users. CCC-Tobacco is a large, pooled cohort dataset that is uniquely designed with increased power to expand knowledge regarding the association of traditional and non-traditional tobacco use with subclinical and clinical CVD, with extension to understudied groups including women and individuals from underrepresented racial-ethnic groups.
format Online
Article
Text
id pubmed-10326890
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
record_format MEDLINE/PubMed
spelling pubmed-103268902023-07-08 Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology Tasdighi, Erfan Jha, Kunal K. Dardari, Zeina A. Osuji, Ngozi Rajan, Tanuja Boakye, Ellen Hall, Michael E. Rodriguez, Carlos J. Stokes, Andrew C. El Shahawy, Omar Benjamin, Emelia J. Bhatnagar, Aruni DeFilippis, Andrew P. Blaha, Michael J. Tob Induc Dis Study Protocols While the impact of combustible cigarette smoking on cardiovascular disease (CVD) is well-established, the longitudinal association of non-traditional tobacco products with subclinical and clinical CVD has not been fully explored due to: 1) limited data availability; and 2) the lack of well-phenotyped prospective cohorts. Therefore, there is the need for sufficiently powered well-phenotyped datasets to fully elucidate the CVD risks associated with non-cigarette tobacco products. The Cross-Cohort Collaboration (CCC)-Tobacco is a harmonized dataset of 23 prospective cohort studies predominantly in the US. A priori defined variables collected from each cohort included baseline characteristics, details of traditional and non-traditional tobacco product use, inflammatory markers, and outcomes including subclinical and clinical CVD. The definitions of the variables in each cohort were systematically evaluated by a team of two physician-scientists and a biostatistician. Herein, we describe the method of data acquisition and harmonization and the baseline sociodemographic and risk profile of participants in the combined CCC-Tobacco dataset. The total number of participants in the pooled cohort is 322782 (mean age: 59.7 ± 11.8 years) of which 76% are women. White individuals make up the majority (73.1%), although there is good representation of other race and ethnicity groups including African American (15.6%) and Hispanic/Latino individuals (6.4%). The prevalence of participants who never smoked, formerly smoked, and currently smoke combustible cigarettes is 50%, 36%, and 14%, respectively. The prevalence of current and former cigar, pipe, and smokeless tobacco is 7.3%, 6.4%, and 8.6%, respectively. E-cigarette use was measured only in follow-up visits of select studies, totaling 1704 former and current users. CCC-Tobacco is a large, pooled cohort dataset that is uniquely designed with increased power to expand knowledge regarding the association of traditional and non-traditional tobacco use with subclinical and clinical CVD, with extension to understudied groups including women and individuals from underrepresented racial-ethnic groups. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2023-07-07 /pmc/articles/PMC10326890/ /pubmed/37427074 http://dx.doi.org/10.18332/tid/166517 Text en © 2023 Tasdighi E. et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
spellingShingle Study Protocols
Tasdighi, Erfan
Jha, Kunal K.
Dardari, Zeina A.
Osuji, Ngozi
Rajan, Tanuja
Boakye, Ellen
Hall, Michael E.
Rodriguez, Carlos J.
Stokes, Andrew C.
El Shahawy, Omar
Benjamin, Emelia J.
Bhatnagar, Aruni
DeFilippis, Andrew P.
Blaha, Michael J.
Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title_full Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title_fullStr Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title_full_unstemmed Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title_short Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
title_sort investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: the cross-cohort collaboration-tobacco working group rationale, design, and methodology
topic Study Protocols
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326890/
https://www.ncbi.nlm.nih.gov/pubmed/37427074
http://dx.doi.org/10.18332/tid/166517
work_keys_str_mv AT tasdighierfan investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT jhakunalk investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT dardarizeinaa investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT osujingozi investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT rajantanuja investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT boakyeellen investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT hallmichaele investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT rodriguezcarlosj investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT stokesandrewc investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT elshahawyomar investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT benjaminemeliaj investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT bhatnagararuni investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT defilippisandrewp investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology
AT blahamichaelj investigatingtheassociationoftraditionalandnontraditionaltobaccoproductusewithsubclinicalandclinicalcardiovasculardiseasethecrosscohortcollaborationtobaccoworkinggrouprationaledesignandmethodology